Sunday Jul 20, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Science & Technology Startup Nation Tech Bits

Alverno Laboratories chooses Ibex's AI-based cancer diagnostics solution

by  Noga Martin/ILH Startup Editor
Published on  08-11-2021 16:00
Last modified: 08-11-2021 12:19
Alverno Laboratories chooses Ibex's AI-based cancer diagnostics solutionibex Medical Analytics

Ibex harnesses artificial intelligence to enable real-time cancer diagnostics | Photo: ibex Medical Analytics

Share on FacebookShare on Twitter

Diagnostic testing services provider Alverno Laboratories and AI-based cancer diagnostics provider Ibex Medical Analytics have closed a deal to deploy Ibex's AI-powered Galen platform, the companies announced Wednesday.

Follow Israel Hayom on Facebook and Twitter

Ibex transforms cancer diagnosis by harnessing Strong AI and machine learning technology. Ibex's Galen platform helps pathologists improve the quality of cancer diagnosis, implement real-time quality control1, reduce diagnosis time and boost productivity. The platform was recently granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) and is CE marked in Europe for breast and prostate cancer detection in multiple workflows.

Alverno is among the first labs in the US to implement digital pathology technologies. By adding Ibex's Galen platform, pathologists at Alverno can be expected to benefit from clinical-grade AI insights available on different workflows and multiple types of tissue.

"We are thrilled to team up with Alverno and enable their pathologists to use state-of-the-art AI solutions to accurately detect cancer and improve quality and efficiency of diagnosis," said Joel Duckworth, Chief Revenue Officer for the Americas at Ibex. "With this roll out, Alverno is setting a new standard in cancer care quality."

Related Posts

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2MGetty Images/iStockphoto

Arieli EL acquires 59.1% stake in Elron Ventures for $53.2M

by ILH Staff

Arieli EL, part of the Arieli group of companies, has announced the acquisition of a 59.1% stake in veteran cyber...

Magnus Metal raises $74M in Series B fundingGetty Images/SARINYAPINNGAM

Magnus Metal raises $74M in Series B funding

by ILH Staff

  Magnus Metal, a company pioneering digital metal casting technology, raised $74 million in Series B funding. This funding will...

Morphisec launches anti-ransomware assurance suite powered by AMTDGetty Images/iStockphoto, gorodenkoff

Morphisec launches anti-ransomware assurance suite powered by AMTD

by ILH Staff

  Morphisec, a leading cybersecurity provider, announced the Anti-Ransomware Assurance Suite, an innovative offering to help organizations reduce cyber risk...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il